Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease
出版年份 2021 全文链接
标题
Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease
作者
关键词
PDE10A inhibitor, Parkinson's disease, Unilateral rat model, L-DOPA, Sensorimotor deficits, Rotation
出版物
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 910, Issue -, Pages 174460
出版商
Elsevier BV
发表日期
2021-08-29
DOI
10.1016/j.ejphar.2021.174460
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- P.105 The study of molecular changes induced by CPL500-036, a potential novel anti-dyskinetic drug, in 6-OHDA rat model of Parkinson's disease
- (2020) A. Gajos-Draus et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ameliorative effects of a phosphodiesterase 10A inhibitor, MR1916 on l-DOPA-induced dyskinesia in parkinsonian rats
- (2020) Keita Arakawa et al. Pharmacological Reports
- The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
- (2020) Do-Yeon Kim et al. Journal of Neuroimmune Pharmacology
- Synthesis and characterization of novel classes of PDE10A inhibitors - 1 H -1,3-benzodiazoles and imidazo[1,2- a ]pyrimidines
- (2018) Rafał Moszczyński-Pętkowski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Selective Phosphodiesterase 10A Inhibitor Reduces L -Dopa-Induced Dyskinesias in Parkinsonian Monkeys
- (2018) Goichi Beck et al. MOVEMENT DISORDERS
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Combined ipsilateral limb use score as an index of motor deficits and neurorestoration in parkinsonian rats
- (2017) Juuso V. Leikas et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The phosphodiesterase 10A selective inhibitor, TAK-063, induces c-Fos expression in both direct and indirect pathway medium spiny neurons and sub-regions of the medial prefrontal cortex in rats
- (2017) Atsushi Nakatani et al. NEUROSCIENCE RESEARCH
- Depressive-like neurochemical and behavioral markers of Parkinson’s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle
- (2017) Kinga Kamińska et al. Pharmacological Reports
- TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms
- (2016) Kazunori Suzuki et al. NEUROPSYCHOPHARMACOLOGY
- Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA
- (2015) Jolanta Konieczny et al. BEHAVIOURAL BRAIN RESEARCH
- Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum
- (2015) Jonathan M. Wilson et al. NEUROPHARMACOLOGY
- The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents
- (2015) Renee C. Gentzel et al. NEUROPHARMACOLOGY
- Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson’s disease
- (2015) C. Fidalgo et al. NEUROSCIENCE
- Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism?
- (2014) Giuseppe Sancesario et al. NEUROCHEMISTRY INTERNATIONAL
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease
- (2014) E. Tronci et al. NEUROSCIENCE
- Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra
- (2013) Jolanta Konieczny et al. BEHAVIOURAL BRAIN RESEARCH
- Phosphodiesterase 10A inhibitor MP-10 effects in primates: Comparison with risperidone and mechanistic implications
- (2013) Subramaniam Uthayathas et al. NEUROPHARMACOLOGY
- Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions
- (2013) Dalila Mango et al. NEUROPHARMACOLOGY
- The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
- (2012) Sean M. Smith et al. NEUROPHARMACOLOGY
- PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology
- (2011) M. Giorgi et al. NEUROBIOLOGY OF DISEASE
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- A new ethyladenine antagonist of adenosine A2A receptors: Behavioral and biochemical characterization as an antiparkinsonian drug
- (2009) Annalisa Pinna et al. NEUROPHARMACOLOGY
- Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A
- (2009) Christine A. Strick et al. NEUROPHARMACOLOGY
- Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms
- (2008) M. Giorgi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
- (2008) A. Nishi et al. JOURNAL OF NEUROSCIENCE
- Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
- (2008) S. Threlfell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
- (2008) C. J. Schmidt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started